These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33968064)

  • 1. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.
    Frange P; Montange T; Le Chenadec J; Batalie D; Fert I; Dollfus C; Faye A; Blanche S; Chacé A; Fourcade C; Hau I; Levine M; Mahlaoui N; Marcou V; Tabone MD; Veber F; Hoctin A; Wack T; Avettand-Fenoël V; Warszawski J; Buseyne F
    Front Immunol; 2021; 12():662894. PubMed ID: 33968064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.
    Yin L; Rodriguez CA; Hou W; Potter O; Caplan MJ; Goodenow MM; Sleasman JW
    J Allergy Clin Immunol; 2008 Jul; 122(1):166-72, 172.e1-2. PubMed ID: 18538835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.
    Piconi S; Trabattoni D; Gori A; Parisotto S; Magni C; Meraviglia P; Bandera A; Capetti A; Rizzardini G; Clerici M
    AIDS; 2010 Aug; 24(13):1991-2000. PubMed ID: 20651586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents.
    Böhler T; Walcher J; Hölzl-Wenig G; Geiss M; Buchholz B; Linde R; Debatin KM
    AIDS; 1999 May; 13(7):779-89. PubMed ID: 10357376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
    Alvarez P; Mwamzuka M; Marshed F; Kravietz A; Ilmet T; Ahmed A; Borkowsky W; Khaitan A
    PLoS One; 2017; 12(12):e0190332. PubMed ID: 29287090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.
    Azzoni L; Barbour R; Papasavvas E; Glencross DK; Stevens WS; Cotton MF; Violari A; Montaner LJ
    PLoS One; 2015; 10(12):e0145320. PubMed ID: 26671450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.
    Han J; Mu W; Zhao H; Hao Y; Song C; Zhou H; Sun X; Li G; Dai G; Zhang Y; Zhang F; Zeng H
    Int J Infect Dis; 2020 Feb; 91():210-217. PubMed ID: 31821891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
    Hua W; Jiao Y; Zhang H; Zhang T; Chen D; Zhang Y; Chen X; Wu H
    Immunol Invest; 2012; 41(1):1-14. PubMed ID: 21563924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J;
    Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence.
    Avettand-Fenoel V; Lechenadec J; Diallo MS; Fillion M; Melard A; Samri A; Dollfus C; Blanche S; Faye A; Amokrane K; Autran B; Buseyne F; Warszawski J; Frange P;
    Clin Infect Dis; 2021 Dec; 73(11):e4214-e4222. PubMed ID: 34355738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease.
    McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
    Front Immunol; 2018; 9():1901. PubMed ID: 30197641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.
    van Rossum AM; Scherpbier HJ; van Lochem EG; Pakker NG; Slieker WA; Wolthers KC; Roos MT; Kuijpers JH; Hooijkaas H; Hartwig NG; Geelen SP; Wolfs TF; Lange JM; Miedema F; de Groot R;
    AIDS; 2001 Nov; 15(17):2267-75. PubMed ID: 11698700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between recent thymic emigrants and CD4+ T-cell recovery after short-term antiretroviral therapy initiation.
    Briceño O; Chávez-Torres M; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Pinto-Cardoso S; Reyes-Terán G
    AIDS; 2020 Mar; 34(4):501-511. PubMed ID: 31794524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.
    Hoffman RM; Jamieson BD; Bosch RJ; Currier J; Kitchen CM; Schmid I; Zhu Y; Bennett K; Mitsuyasu R
    J Clin Immunol; 2011 Oct; 31(5):873-81. PubMed ID: 21643890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.